Latest Biotechnology, Pharmaceutical and Healthcare News from PMLIVE

18:27 EDT 20th September 2018 | BioPortfolio

Here are the most relevant search results for "PMLIVE" found in our extensive news archives from over 250 global news sources.

More Information about PMLIVE on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PMLIVE for you to read. Along with our medical data and news we also list PMLIVE Clinical Trials, which are updated daily. BioPortfolio also has a large database of PMLIVE Companies for you to search.

Showing News Articles 1–25 of 966 from PMLIVE

Thursday 20th September 2018

Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands

The latest healthcare comms movers

Hanover Health launches award, Firstlight spins off healthcare arm and more

The latest news in healthcare comms

J&J files ‘breakthrough’ bladder cancer drug in US

Needed as most patients don't respond to checkpoint inhibitors

Boehringer’s Corsico to be new GSK drug dev leader

Research and drug development will be split into separate divisions

Anna Korving to step down as Chair of Communiqué Awards judging panel

Annabelle Sandeman and Louise Dunn are set to take the reins

CRUK forges £30m ‘post-Brexit’ R&D alliance

Joins forces with organisations in Italy and Spain

Wednesday 19th September 2018

Innovate UK supports AI drug discovery project worth £1m

Project aims to use deep learning to utilise complex medicine data

Nurturing the growth mindset: The need for ongoing professional development in strategic medical communications

Writing is a skill, a craft, an art

Kymriah rejected in DLBCL - but NICE wants to keep talking about cost effectiveness

Kymriah faces harder test in DLBCL - especially with Yescarta competition

Biotech leaders jump into US free speech debate

Senior biotech execs sign a letter in defence of free speech

Viking throws down gauntlet in NASH battle

Biotech is challenging rival Madrigal in 'next big thing' disease area

Q&A: Jenny Squibbs The best and worst things about working in healthcare comms

Gemma Jones interviews 90TEN's senior account director

Tuesday 18th September 2018

Tox trouble stalls Sosei/Allergan Alzheimer’s drug

Surprise findings from primate studies

London cancer hub launched by Cancer Research UK

Specialist centres unite to collaborate on immunotherapies such as CAR-T

Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma

Proactive adjuvant treatment could extend melanoma patient lives

Monday 17th September 2018

AZ prepares to file COPD triple, taking on rival GSK

Latest salvo in combination trials competition

Controversy grows around GP at Hand service after minister’s endorsement

Hancock says service should be rolled out across England

Teva wins FDA OK for crucial migraine drug

Vital to Teva's turnaround, Ajovy will challenge Novartis/Amgen's Aimovig

Friday 14th September 2018

AZ nabs US approval for new leukaemia drug Lumoxiti

Adds to firm's growing oncology franchise

Gilead targets hep B in half a billion dollar deal with Precision BioSciences

Biopharma looks to genome editing platform to discover hepatitis B cure

New data keeps AbbVie’s star pipeline therapies on track

Data showed 56% of patients on risankizumab were symptom free after a year’s treatment

‘Streamlined’ medicines regulation promised in ‘No Deal’ Brexit scenario

UK would miss out on new EU clinical trial regulations

Thursday 13th September 2018

Saatchi and Saatchi Wellness London launch IVF campaign

The advertising agency targets fair access to IVF treatments

Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline

Dieter Weinand to be based in key US market

Shire’s bleeding disorder drug approved in Europe

Veyvondi for patients with rare disease von Willebrand disease

Quick Search


News Quicklinks